EP2004203A4
Formulations of low dose diclofenac and beta-cyclodextrin
Abstract
This record has no abstract on file.
Term
Projected expiry 22 March 2027.
- Priority
- Filed
- Published
- Today
- Projected expiry
3 sheets
Sheet 1 Sheet 2 Sheet 3
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| EP0268215A1 | Cites | European Patent Office (EPO) | X | Search report | 1-15 |
| WO9614839A1 | Cites | World Intellectual Property Organization (WIPO) | I | Search report | 1-15 |
| JAMBHEKAR S. ET AL: "The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin complexes", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 270, no. 1-2, 11 February 2004 (2004-02-11), Netherland, pages 149 - 166, XP002568841 | Non-patent | – | – | Search report | – |
| BARBATO F. ET AL: "Diclofenac beta-Cyclodextrin Binary Systems: A Study in Solution and in the Solid State", JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, vol. 46, August 2003 (2003-08-01), pages 179 - 185, XP002568842 | Non-patent | – | – | Search report | – |
| REDDY ET AL: "beta Cyclodextrin Complexes of Celecoxib: Molecular Moedling, Characterization, and Dissolution Studies", AAPS OHARM SCI, vol. 6, no. 1, 7, 5 March 2004 (2004-03-05), pages 1-9, XP002568843 | Non-patent | – | – | Search report | – |
| See also references of WO 2007112272A2 | Non-patent | – | – | Search report | – |
38 members in 12 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 786486P | United States of America | – | |
| 78648606 | United States of America | P | |
| 2007064678 | United States of America | W |
Members38
| Document | Office | Kind | |
|---|---|---|---|
| AU2007230716A1 | Australia | A1 | |
| CA2647348A1 | Canada | A1 | |
| US2007232566A1 | United States of America | A1 | |
| WO2007112272A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007112272A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2004203A2 | European Patent Office (EPO) | A2 | |
| KR20080112285A | Republic of Korea | A | |
| MX2008012495A | Mexico | A | |
| CN101410123A | China | A | |
| IL194185A0 | Israel | A0 | |
| IL194185D0 | Israel | D0 | |
| JP2009531450A | Japan | A | |
| ZA200808115B | South Africa | B | |
| EP2004203A4This record | European Patent Office (EPO) | A4 | |
| BRPI0709409A2 | Brazil | A2 | |
| US2011218247A1 | United States of America | A1 | |
| AU2007230716B2 | Australia | B2 | |
| AU2012209035A1 | Australia | A1 | |
| EP2522343A1 | European Patent Office (EPO) | A1 | |
| EP2522344A1 | European Patent Office (EPO) | A1 | |
| CN102846585A | China | A | |
| US8580954B2 | United States of America | B2 | |
| JP2014005309A | Japan | A | |
| KR20140038575A | Republic of Korea | A | |
| US2014107209A1 | United States of America | A1 | |
| AU2012209035B2 | Australia | B2 | |
| AU2012209035B9 | Australia | B9 | |
| IL194185A | Israel | A | |
| US8946292B2 | United States of America | B2 | |
| US2015105467A1 | United States of America | A1 | |
| KR20150050595A | Republic of Korea | A | |
| JP5823093B2 | Japan | B2 | |
| JP2016040327A | Japan | A | |
| KR20160033796A | Republic of Korea | A | |
| IL222432A | Israel | A | |
| JP6157305B2 | Japan | B2 | |
| KR20170123724A | Republic of Korea | A | |
| JP6265964B2 | Japan | B2 |
11 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Application refused18R | 18R | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN REFUSEDSTAA | STAA | EP | |
| Refusal decision now finalR003 | R003 | DE | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2004203
- Application
- 77591568
Titles3
- German
- FORMULIERUNGEN AUS NIEDRIGDOSIERTEM DICLOFENAC UND BETA-CYCLODEXTRIN
- English
- FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN
- French
- FORMULATIONS DE DICLOFÉNAC ET DE CYCLODEXTRINE BÊTA À FAIBLE DOSAGE
Classification
- CPC, 14
- A61K31/195
- A61K47/40
- A61K31/724
- A61K31/196
- A61P25/04
- A61P29/00
- A61K9/0019
- A61K9/02
- A61K9/08
- A61K9/14
- C08B37/0015
- A61K2300/00
- C07H3/06
- C07H15/04
- IPC, 2
- A61K31 724
- A61P29 00
Designated states32
- Contracting states, 32
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Malta
and 8 moreShow fewer
- Netherlands (Kingdom of the)
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye